Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
about
Ring finger protein ZIN interacts with human immunodeficiency virus type 1 VifThe cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNAAn endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group.Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsHuman APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replicationHIV-1 Vif and APOBEC3G: multiple roads to one goalA second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteinsA single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletionThe restriction factors of human immunodeficiency virusHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityInhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyComprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsIntracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.The APOBEC3 family of retroelement restriction factorsSuppression of APOBEC3-mediated restriction of HIV-1 by VifFeline immunodeficiency virus Vif localizes to the nucleusMode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactionsEndogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2nAPOBEC3G: an intracellular centurionMultiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.SIV replication in human cellsImplication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.Novel approaches to inhibiting HIV-1 replication.Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replicationRequirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels.Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Species-specific, postentry barriers to primate immunodeficiency virus infection.Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
P2860
Q24304030-AE9598EF-450D-4A8F-8023-894DF79007FDQ24305266-47C8BF2F-C883-4E3A-9FF4-7CEBD3983533Q24523705-1924514A-5943-4AB3-B3F7-A5EC6A01334FQ24524085-73565127-1809-4BF8-854C-2D1AC28FF63BQ24537623-00048982-5382-4091-9C2D-51086A86C82BQ24563503-019D37DD-6DE1-45FC-8E1E-E8B1AA949040Q24564072-7867AE12-29A7-4DE1-8B87-A55D302FBC3FQ24564187-0E84ABF8-521E-4BEE-BF80-9563C61C6EDCQ24568052-F4B0EBBB-F32E-4203-BF03-8D5A872A2C74Q24605108-024AE3C7-8E0B-4B03-BCBE-B1D9657ED5A9Q24619114-37BCEA5C-190F-41A8-81C3-088CF1B93E18Q24647833-A14BD7B9-ED18-4F65-B5AD-8A95DBA3CD0BQ24669993-4081E35D-47A4-486E-A28C-C2B51328B5E1Q24670173-C345C960-B279-443D-A99D-A884898C4520Q24678970-8DB4FA72-5B04-44BB-B33B-3B8363AC6B19Q24805644-35FCFC91-FD6A-4287-BE1A-31F46238B487Q26862780-8C62AEEB-63A5-4556-B224-64A6985DE79EQ27025150-C0D8BD30-AF8D-4396-BE84-99BF9EAA6F3AQ27469637-EA5BBB62-4A5B-400E-A657-66CEF09C80ABQ28368846-43E58E8A-2264-4C4C-B635-EA17DE5BEBEAQ28481286-D8E377CF-6670-44C5-9A14-C13FFC71B63DQ28754989-2CE3A6D4-62E4-436E-90F0-73D860E04A39Q30381745-82704871-A713-4BEF-8158-B8A64EBA584FQ30417737-751D7130-6D62-442C-B8A5-A8E8F38405FFQ30860339-D51388FB-7689-4335-8B6D-3BBF0A24D084Q33289183-E20DF877-F5CC-4258-AFC2-9BB3E6BF0278Q33602923-DDBFB858-7FE5-47D1-B20D-73B19BDC0F68Q33614365-BFDB684B-33D1-4BC8-902C-7CFEEA04DA67Q33624690-F3357EC2-CCE3-4C49-A6DF-5AB0F4CE64D0Q33631183-8CFC03B7-6733-45C4-BD07-0876DC8B4EB5Q33652758-9D7CA9AB-5CA1-47B6-A1E1-4D8160F9744AQ33654949-22E95014-F2F3-4970-88B0-2EBD30B90A22Q33782866-B78CF028-0D2B-474D-A1A2-452EBA3AA474Q33783386-1325FD14-D3DF-425C-A8BF-D9313C00AC7EQ33806688-7DC14DCD-1413-4CA5-BB5B-F0C75058FB15Q33813747-FE0C5FB6-3DB7-4A1D-B2E5-EFBE6129F8A4Q33814215-26743709-5B9F-4594-A64A-66555D65921BQ33815187-CADF1B6A-77FF-438C-A981-C262A28AEE54Q33824990-7272F126-9CCA-4B79-A79D-D2DD678CBB78Q33841920-8CBA0433-D2BF-4849-97BA-D4BD6149EB4D
P2860
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
@ast
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
@en
type
label
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
@ast
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
@en
prefLabel
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
@ast
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
@en
P2093
P2860
P1433
P1476
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
@en
P2093
D H Gabuzda
E Langhoff
E Terwilliger
J Sodroski
K Lawrence
P2860
P304
P407
P577
1992-11-01T00:00:00Z